The makers of Sputnik V Covid-19 vaccine, the Russian Direct Investment Fund (RDIF), are now expecting India to approve their vaccine following encouraging results on its efficacy. Read More
Covid vaccine Sputnik V has 91.6% efficacy, Lancet report says. Makers expecting India nod
Reading Time: minute